Search company, investor...
ApoGen Biotechnologies company logo

ApoGen Biotechnologies

apogenbiotech.com

Founded Year

2014

Stage

Series A - II | Alive

Total Raised

$11M

Last Raised

$4M | 5 yrs ago

About ApoGen Biotechnologies

ApoGen Biotechnologies is a biotechnology company focused on the development of therapeutics targeting drivers of cancer genomic mutation. ApoGen is building upon technologies developed at the University of Minnesota to develop drugs that block a key pathway that causes drug resistance. ApoGen's drug discovery and development efforts are directed toward selective and potent small molecule inhibitors of the APOBEC family of enzymes, which are DNA cytosine deaminases and an endogenous source of DNA mutation in cancer.

Headquarters Location

2815 Eastlake Avenue East Suite 300

Seattle, Washington, 98102,

United States

206-957-7300

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Latest ApoGen Biotechnologies News

ApoGen expands series A to $11M

Sep 3, 2018

ApoGen expands series A to $11M 11:13 AM PDF Drug-resistant cancer company ApoGen Biotechnologies Inc. raised an additional $4 million on Aug. 23 from M Ventures and existing investors in its series A round, bringing the round's total to $11 million. M Ventures is the venture arm... Read the full 166 word article User Sign in

ApoGen Biotechnologies Frequently Asked Questions (FAQ)

  • When was ApoGen Biotechnologies founded?

    ApoGen Biotechnologies was founded in 2014.

  • Where is ApoGen Biotechnologies's headquarters?

    ApoGen Biotechnologies's headquarters is located at 2815 Eastlake Avenue East, Seattle.

  • What is ApoGen Biotechnologies's latest funding round?

    ApoGen Biotechnologies's latest funding round is Series A - II.

  • How much did ApoGen Biotechnologies raise?

    ApoGen Biotechnologies raised a total of $11M.

  • Who are the investors of ApoGen Biotechnologies?

    Investors of ApoGen Biotechnologies include WRF Capital, M Ventures, ARCH Venture Partners, Eli Lilly and Company, WuXi AppTec and 8 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.